Cornerstone Therapeutics Inc. (NASDAQ:CRTX)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.

Recs

0
Player Avatar Haugurafpeningum (85.94) Submitted: 11/8/2011 2:05:24 AM : Outperform Start Price: $5.89 CRTX Score: -18.51

Technical Monthly

Featured Broker Partners


Advertisement